Loading...
Vous êtes en train de visualiser un fichier supprimé.
Cette information sur le fichier est montrée à des fins de référence seulement et ne doit pas être utilisée.
Ce document a été mis à jour. Il ne s’agit pas de la dernière version publiée. Cliquez ici pour voir la dernière version du fichier.
Certificat de respect des obligations internationalement reconnu
(IRCC)
Voir l'historique des modifications pour plus d'informations.
last updated: 07 juin 2023
ABSCH-IRCC-IN-264481-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndeTéléphone : +91 44 2254 2777,Télécopieur : +91 44 2254 1200,Site Web : http://www.nbaindia.org,
India/NBA/Appl/9/INBA3202102900
Application in Form-III for seeking approval for the invention on “ Enhancement of Incretin Hormones with Glycyrrhiza glabra as a Potential Lead In Diabetic Treatment ” for obtaining IP rights in India.
Indian Patent Application No.- 518/CHE/2015
03 avr. 2023
Oui
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndeTéléphone : +91 44 2254 2777,Télécopieur : +91 44 2254 1200,Site Web : http://www.nbaindia.org,
Informations confidentielles
Informations confidentielles
Oui
1. The user shall notify NBA within 60 days from the date of grant of IPR and also assignment or license of the IPR if any, to any person.
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.4% on the annual gross ex-factory sale minus government taxes.
3. The user shall inform NBA about any commercialization made on the IP Rights.
4. The user shall submit annual report to NBA as per the terms and conditions agreed upon.
Informations confidentielles
Informations confidentielles
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 4.0% of the fee received (in any form including the license / assignee fee) and 4.0% of the royalty amount received annually from the assignee/licensee.
2. In case the user assigns or transfers the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument which shall be binding upon such person.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-264481-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Satyendra Kumar (satyendra.kumar07@nic.in)
07 juin 2023 08:51 on 07 juin 2023 08:51
|
